Latest Net Tangible Assets News

WAM Income Maximiser has raised its fully franked monthly dividends for Q3 2026, riding on an investment portfolio that has outperformed benchmarks by 8% annually since inception with notably lower volatility.

NAOS EX-50 Opportunities Company Limited has initiated an on-market buy-back program targeting up to 4.58 million shares, representing 10% of its issued capital, to run from June 2026 through to June 2027.

MFF Capital Investments’ May update shows a modest fall in net tangible assets per share and outlines a cautious yet optimistic portfolio stance amid geopolitical tensions and technological advances.

Third Age Health Services posted a 17.9% revenue increase and 24.7% profit rise for FY26, driven by strategic acquisitions and expansion in aged residential care services.

Amplia Therapeutics reported encouraging mature data from its ACCENT pancreatic cancer trial showing improved survival and response rates with narmafotinib. The company raised $27.5 million to fund development and manufacturing scale-up, while discontinuing a parallel trial due to chemotherapy toxicity.

New Talisman Gold Mines boosted revenue by 121% to NZ$53,000 but posted a $2.26 million net loss as it commissioned a processing plant and secured key commercial agreements.

WAM Income Maximiser (ASX: WMX) has outpaced its benchmark with an 18.1% portfolio increase and exceeded its dividend target by delivering a 7.0% fully franked yield in its first year since April 2025.

Promisia Healthcare reported a robust 29% increase in operating revenue for FY26, alongside a new dividend policy tied to operating free cash flow, setting the stage for continued growth in FY27.

ASX Limited projects a significant 18-21% rise in expenses for FY27 driven by technology modernisation and regulatory response, while increasing capital expenditure guidance to up to $200 million.

Goodman NZ surged to a $248 million statutory profit in FY26, propelled by strong property revaluations and leasing gains, while advancing major development projects and transitioning to a stapled group structure.

Ryman Healthcare reported a substantial reduction in net loss for FY26 alongside its first positive free cash flow in over a decade, driven by operational improvements, refinancing, and land divestments.

Alternative Investment Trust (AIQ) has issued 7.39 million units at A$1.38 each, raising A$10.2 million from wholesale investors without a product disclosure statement. The capital raise aligns with AIQ’s adjusted net tangible asset value and complies with Corporations Act requirements.